Cardlytics (NASDAQ:CDLX) CFO Acquires $97,500.00 in Stock

Cardlytics, Inc. (NASDAQ:CDLXGet Free Report) CFO David Thomas Evans purchased 150,000 shares of the firm’s stock in a transaction on Friday, May 15th. The stock was bought at an average cost of $0.65 per share, for a total transaction of $97,500.00. Following the completion of the purchase, the chief financial officer directly owned 267,930 shares in the company, valued at approximately $174,154.50. This trade represents a 127.19% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available through this hyperlink.

David Thomas Evans also recently made the following trade(s):

  • On Monday, May 18th, David Thomas Evans purchased 50,000 shares of Cardlytics stock. The stock was bought at an average cost of $0.63 per share, for a total transaction of $31,500.00.

Cardlytics Price Performance

Shares of Cardlytics stock opened at $0.73 on Friday. The business’s 50 day simple moving average is $0.87 and its two-hundred day simple moving average is $1.03. The stock has a market capitalization of $41.97 million, a P/E ratio of -0.41 and a beta of 0.67. Cardlytics, Inc. has a one year low of $0.57 and a one year high of $3.28.

Cardlytics (NASDAQ:CDLXGet Free Report) last announced its quarterly earnings results on Wednesday, March 4th. The company reported ($0.15) EPS for the quarter, missing analysts’ consensus estimates of ($0.07) by ($0.08). The company had revenue of $56.10 million during the quarter, compared to analysts’ expectations of $54.46 million. Cardlytics had a negative return on equity of 956.56% and a negative net margin of 46.03%. Sell-side analysts expect that Cardlytics, Inc. will post -0.11 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Cardlytics

Large investors have recently made changes to their positions in the business. Vanguard Personalized Indexing Management LLC bought a new stake in shares of Cardlytics during the third quarter valued at approximately $26,000. Goldman Sachs Group Inc. boosted its position in shares of Cardlytics by 15.1% during the fourth quarter. Goldman Sachs Group Inc. now owns 109,001 shares of the company’s stock valued at $125,000 after purchasing an additional 14,273 shares in the last quarter. Geode Capital Management LLC boosted its position in shares of Cardlytics by 3.3% during the fourth quarter. Geode Capital Management LLC now owns 654,472 shares of the company’s stock valued at $753,000 after purchasing an additional 20,908 shares in the last quarter. Qube Research & Technologies Ltd bought a new stake in shares of Cardlytics during the third quarter valued at approximately $55,000. Finally, Boothbay Fund Management LLC bought a new stake in shares of Cardlytics during the third quarter valued at approximately $74,000. 68.10% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

A number of brokerages have recently weighed in on CDLX. Bank of America reiterated an “underperform” rating on shares of Cardlytics in a research report on Thursday, March 5th. Evercore set a $1.00 price objective on Cardlytics in a research report on Friday, March 6th. Lake Street Capital set a $1.00 price objective on Cardlytics in a research report on Friday, May 8th. Wall Street Zen upgraded Cardlytics from a “sell” rating to a “hold” rating in a research report on Saturday, April 4th. Finally, Weiss Ratings reiterated a “sell (e+)” rating on shares of Cardlytics in a research report on Friday, April 10th. One analyst has rated the stock with a Hold rating and two have assigned a Sell rating to the company’s stock. According to MarketBeat.com, Cardlytics currently has an average rating of “Sell” and a consensus target price of $1.00.

View Our Latest Analysis on CDLX

Cardlytics Company Profile

(Get Free Report)

Cardlytics, Inc operates a purchase intelligence and marketing platform that connects advertisers with consumers through bank and credit card transaction data. The company partners with financial institutions to analyze anonymized purchase information, enabling brands to deliver highly targeted offers and rewards directly to customers’ online and mobile banking channels. By leveraging real-time insights into consumer spending habits, Cardlytics helps marketers optimize campaign performance and measure return on ad spend more accurately than traditional digital advertising methods.

At the core of Cardlytics’ offering is its proprietary purchase intelligence engine, which aggregates and anonymizes transaction data from partner banks and credit unions.

Featured Articles

Insider Buying and Selling by Quarter for Cardlytics (NASDAQ:CDLX)

Receive News & Ratings for Cardlytics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardlytics and related companies with MarketBeat.com's FREE daily email newsletter.